Ligand Pharmaceuticals, Inc. (LGND)
318.78
+7.05
(+2.26%)
USD |
NASDAQ |
Oct 28, 16:00
318.00
-0.78
(-0.24%)
After-Hours: 20:00
Ligand Pharmaceuticals Price : 318.78 for Oct. 28, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 28, 2026 | 311.62 | 319.90 | 309.69 | 318.78 | 268467.0 |
| Oct 27, 2026 | 308.51 | 314.19 | 307.55 | 311.73 | 143353.0 |
| Oct 26, 2026 | 304.39 | 309.43 | 303.47 | 308.30 | 194782.0 |
| Oct 23, 2026 | 307.82 | 313.28 | 302.37 | 303.53 | 366546.0 |
| Oct 22, 2026 | 313.00 | 315.27 | 305.34 | 307.82 | 315136.0 |
| Oct 21, 2026 | 305.36 | 317.64 | 303.93 | 314.78 | 222760.0 |
| Oct 20, 2026 | 298.61 | 314.05 | 298.61 | 306.40 | 171729.0 |
| Oct 19, 2026 | 300.41 | 303.86 | 295.74 | 297.28 | 116995.0 |
| Oct 16, 2026 | 297.67 | 297.67 | 292.56 | 295.54 | 164511.0 |
| Oct 15, 2026 | 298.18 | 304.60 | 296.85 | 298.50 | 332112.0 |
| Oct 14, 2026 | 299.55 | 307.11 | 292.28 | 294.99 | 245284.0 |
| Oct 13, 2026 | 311.72 | 311.72 | 300.23 | 303.53 | 196563.0 |
| Oct 12, 2026 | 302.50 | 311.86 | 300.00 | 311.13 | 173183.0 |
| Oct 09, 2026 | 294.79 | 304.78 | 294.32 | 301.81 | 183047.0 |
| Oct 08, 2026 | 290.41 | 296.48 | 281.74 | 295.00 | 318882.0 |
| Oct 07, 2026 | 293.63 | 301.26 | 292.47 | 293.26 | 309238.0 |
| Oct 06, 2026 | 309.41 | 309.41 | 293.72 | 296.94 | 163743.0 |
| Oct 05, 2026 | 303.95 | 309.77 | 300.79 | 306.77 | 163820.0 |
| Oct 02, 2026 | 307.55 | 307.63 | 301.32 | 302.96 | 179228.0 |
| Oct 01, 2026 | 309.82 | 312.05 | 301.48 | 302.74 | 374019.0 |
| Sep 30, 2026 | 310.52 | 317.23 | 306.95 | 312.37 | 505862.0 |
| Sep 29, 2026 | 313.63 | 317.10 | 304.36 | 310.36 | 430962.0 |
| Sep 28, 2026 | 299.78 | 314.94 | 299.70 | 314.10 | 241742.0 |
| Sep 25, 2026 | 303.17 | 305.34 | 293.90 | 301.52 | 305797.0 |
| Sep 24, 2026 | 296.95 | 303.41 | 296.37 | 299.04 | 210275.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 271.04 |
| Eli Lilly & Co. | 1288.30 |
| Merck & Co., Inc. | 140.93 |
| ANI Pharmaceuticals, Inc. | 71.71 |
| Corcept Therapeutics, Inc. | 86.28 |
Price Related Metrics
| PE Ratio | 34.08 |
| PS Ratio | 22.90 |
| Price to Book Value | 6.563 |
| Price to Free Cash Flow | 55.53 |
| Earnings Yield | 2.93% |
| Market Cap | 6.350B |
| Operating PE Ratio | 66.47 |
| Normalized PE Ratio | 45.30 |